ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1768

Sex-Related Differences in Healthcare Utilization in Patients with Inflammatory Arthritis: A Population-based Study

Sanjana Tarannum1, Jessica Widdifield1, C. Fangyun Wang2, Sindhu R. Johnson3, Paula Rochon1 and Lihi Eder4, 1University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 4Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Epidemiology, gender, Psoriatic arthritis, rheumatoid arthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Epidemiology and Public Health Poster III

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Delayed diagnosis of inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), is associated with joint damage and disability. Thus, timely rheumatology access is necessary for favorable disease outcomes. Sex of the patient may influence various aspects of IA including healthcare utilization patterns. Our aim was to compare patterns of musculoskeletal (MSK)-related healthcare utilization before and after diagnosis of IA between male and female patients.

Methods: We assembled 3 inception cohorts of adult RA, AS and PsA patients diagnosed between April 2010 and March 2017 using health administrative data from Ontario, Canada. Healthcare utilization in terms of visits to physicians for MSK causes, MSK imaging and laboratory tests was assessed yearly for 3 years before and 3 years after the diagnosis date and compared between male and female patients. Among individuals ≥ 66 years at the time of diagnosis, dispensation of rheumatic medications was ascertained. Regression models were used to compare healthcare utilization indicators between male and female patients after adjusting for socio-demographic factors and comorbidities. Results were reported as adjusted odds ratios (OR) for female patients compared to males.

Results: A total of 41,277 patients with RA (69% females), 8,150 patients with AS (51% females) and 6,446 patients with PsA (54% female) were analyzed. Multi-morbidity, depression and osteoporosis were more common in female patients and cardiovascular disease in male patients across the 3 cohorts.

Similar trends of sex-related differences were observed in all three IA cohorts. Female patients were more likely to visit family physicians (OR 1.03 to 1.15) and rheumatologists (OR 1.32 to 2.28) especially in earlier pre-diagnosis periods (Figure 1). Male patients were more likely to visit the emergency department immediately before diagnosis (OR 0.76 to 0.78). A similar female predominance was observed in imaging modalities of X-rays (Figure 2) and laboratory tests (OR 1.10 to 2.17) before diagnosis across the three cohorts.

Dispensation of rheumatic medications showed disease specific findings. Female AS patients were more likely to be dispensed conventional disease modifying anti-rheumatic drugs (csDMARDs) whereas female RA patients had higher odds for being dispensed NSAIDs and opioid medications. (Figure 3)

Conclusion: Female patients with IA have higher MSK-related healthcare utilization compared with male patients which may indicate sex-related, biological differences in disease course or gender-related, sociocultural differences in patient behaviour, access to care and interaction with care providers.

Supporting image 1

Figure 1. Adjusted odds ratios for visits to physicians for MSK reasons for female compared to male patients with IA

Supporting image 2

Figure 2. Adjusted odds ratios for MSK imaging for female compared to male patients with IA

Supporting image 3

Figure 3. Adjusted odds ratios for dispensation of medications for female compared to male older patients with IA (age>65)


Disclosures: S. Tarannum, None; J. Widdifield, None; C. Wang, None; S. Johnson, None; P. Rochon, None; L. Eder, AbbVie, Lilly, Novartis, UCB, Pfizer.

To cite this abstract in AMA style:

Tarannum S, Widdifield J, Wang C, Johnson S, Rochon P, Eder L. Sex-Related Differences in Healthcare Utilization in Patients with Inflammatory Arthritis: A Population-based Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sex-related-differences-in-healthcare-utilization-in-patients-with-inflammatory-arthritis-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-related-differences-in-healthcare-utilization-in-patients-with-inflammatory-arthritis-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology